Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)

China flag China · Delayed Price · Currency is CNY
9.83
-0.15 (-1.50%)
Apr 28, 2026, 3:00 PM CST
Market Cap19.40B +30.3%
Revenue (ttm)2.95B +46.7%
Net Income1.22B
EPS0.62
Shares Out1.94B
PE Ratio16.10
Forward PE30.71
Dividend0.30 (3.12%)
Ex-Dividend DateJun 25, 2025
Volume56,258,888
Average Volume85,075,288
Open10.08
Previous Close9.98
Day's Range9.77 - 10.08
52-Week Range7.22 - 10.67
Beta0.28
RSI56.69
Earnings DateApr 20, 2026

About SHA:600867

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metfor... [Read more]

Sector Healthcare
Founded 1985
Employees 3,410
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600867
Full Company Profile

Financial Performance

Financial Statements